Skip to main content

Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide

NDC 0093-5004 · Teva Pharmaceuticals USA, Inc.

Generic nameOlmesartan Medoxomil, Amlodipine and Hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 25; 40 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

0093-5004-56 — 30 TABLET, FILM COATED in 1 BOTTLE (0093-5004-56)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0078-0559 — amlodipine valsartan and hydrochlorothiazide, 0078-0560 — amlodipine valsartan and hydrochlorothiazide, 0078-0561 — amlodipine valsartan and hydrochlorothiazide, 0078-0562 — amlodipine valsartan and hydrochlorothiazide, 0078-0563 — amlodipine valsartan and hydrochlorothiazide, 0093-3241 — bisoprolol fumarate and hydrochlorothiazide, 0093-3242 — bisoprolol fumarate and hydrochlorothiazide, 0093-3243 — bisoprolol fumarate and hydrochlorothiazide, 0093-5002 — Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide, 0093-5003 — Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide, 0093-5005 — Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide, 0093-5006 — Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide, 0093-7367 — Losartan Potassium and Hydrochlorothiazide, 0093-7368 — Losartan Potassium and Hydrochlorothiazide, 0093-7369 — Losartan Potassium and Hydrochlorothiazide, 0093-8232 — Irbesartan and Hydrochlorothiazide, 0093-8238 — Irbesartan and Hydrochlorothiazide, 0172-2083 — Hydrochlorothiazide, 0172-2089 — Hydrochlorothiazide, 0172-3444 — Hydrochlorothiazide, +1450 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels